Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Aniracetam
Cat. No.:
OB0225LY-0218
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Aniracetam is a compound that acts on the central nervous system and helps improve neuronal function.
Synonym:
Ro 13-5057; 72432-10-1; Draganon; Sarpul; 1-(4-Methoxybenzoyl)-2-pyrrolidinone; 1-(4-Methoxybenzoyl)pyrrolidin-2-one; Ampamet; 1-p-Anisoyl-2-pyrrolidinone; Memodrin; 1-anisoyl-2-pyrrolidinone
CAS No.:
72432-10-1
Compound CID:
2196
Formula:
C12H13NO3
Formula Weight:
219.24
Specification
Relative Density:
1.236 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Aniracetam can be used for cognitive function studies or play an important role in neuroscience experiments.
Library Information
Targets:
iGluR; 5-HT receptor; AChR; GluR; Dopamine receptor
Receptors:
nAChR
Pathways:
GPCR/G protein; Neuronal signaling; Membrane transporter/Ion channel
Plate Number:
AOCL-3
Plate Location:
g2
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
35 mg/mL; 159.64 mM
Ethanol Max Solubility:
5.5 mg/mL; 25 mM
